Earl Douglas - SVP, General Counsel at Allogene Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP, General Counsel
Issuer Symbol
ALLO on Nasdaq
All Insider Reports
All Insider Reports

Earl Douglas - trading volume in the past year for Allogene Therapeutics, Inc.

Holdings reported by Earl Douglas for Allogene Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 564,948 $994,308 $1.76 02 Feb 2026 Direct
Stock Option (Right to buy) 539,072 02 Feb 2026 Direct Common Stock
Restricted Stock Unit 152,480 02 Feb 2026 Direct Common Stock

Transactions reported by Earl Douglas for Allogene Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.